Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Infections × golimumab × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Spondylitis, Ankylosing 1 Infections 1 Arthritis, Rheumatoid 1

Interventions

tocilizumab 1 golimumab 1 gilteritinib 1 Tumor Necrosis Factor Inhibitors 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Saline Solution 1 Probiotics 1 Polymerase Chain Reaction 1 Observation 1 Levofloxacin 1 Infliximab 1 Immunoenzyme Techniques 1 Etanercept 1 Docosahexaenoic Acids 1 Clarithromycin 1 Cefoxitin 1 Cefepime 1 Bronchoscopy 1 Bronchoalveolar Lavage 1 Antibiotic Prophylaxis 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04115423 2020-09-10

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab

Sungkyunkwan University

Arthritis, Rheumatoid, Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡